查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930040

抗生素市場規模、佔有率、成長及全球產業分析：按類型、應用和地區劃分的洞察與預測（2025-2034）

Antibiotics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 186 Pages | 商品交期: 請詢問到貨日

價格

抗生素市場成長驅動因子

全球抗生素市場在現代醫療保健中發揮著至關重要的作用，用於治療影響全球數百萬患者的各種細菌感染。抗生素常用於治療呼吸道感染、泌尿道感染、皮膚感染、胃腸道感染、敗血症和其他嚴重疾病。儘管人們對抗菌素抗藥性 (AMR) 的擔憂日益加劇，但抗生素仍然至關重要，從而推動了持續的市場需求。

市場規模與預測

根據 Fortune Business Insights 的數據，2025 年全球抗生素市值為 431.7 億美元。預計到 2026 年，市場規模將成長至 448.4 億美元，到 2034 年將達到 643.8 億美元，在預測期（2026-2034 年）內，複合年增長率 (CAGR) 為 4.40%。

北美地區在 2025 年佔市場主導地位，市場佔有率為 45.44%，這得益於其先進的醫療保健基礎設施、較高的處方率以及大型製藥公司的強大影響力。

市場驅動因素

抗生素市場的主要驅動因素之一是全球細菌感染的日益普遍。結核病、肺炎、泌尿道感染、手術部位感染和血流感染等疾病的持續增加，使得對有效抗菌療法的需求不斷增長。

例如，根據世界衛生組織發布的 "2024年全球結核病報告" ，2023年全球約有1,080萬人感染結核病。此外，醫療相關感染（HAI）仍然是一個重大問題，全球每十名患者中就有一名受到影響，尤其是在中低收入國家。這些因素顯著推動了抗生素的消費和市場成長。

另一個主要驅動因素是研發活動的增加，特別著重於利用新型和聯合抗菌療法來應對抗藥性感染。

市場限制因子

儘管需求強勁，但由於旨在遏制抗生素濫用和過度使用的嚴格法規，市場仍面臨一些限制因素。各國政府和衛生部門正在積極實施抗菌藥物管理計劃，以對抗抗菌素抗藥性 (AMR)。

根據醫學期刊 "刺胳針" 發表的數據，2021 年有 114 萬人死於抗生素抗藥性，如果目前的趨勢持續下去，預計到 2050 年，每年因抗生素抗藥性導致的死亡人數將高達 1000 萬人。此外，預計到 2050 年，因抗菌素抗藥性造成的醫療保健成本將增加 1 兆美元，這將進一步加重醫療保健系統的負擔，並限制抗生素的使用。

市場機會

抗生素抗藥性感染的增加為開發新型和先進的抗生素療法提供了巨大的機會。製藥公司越來越關注聯合用藥和下一代抗生素。

例如，2025 年 2 月，艾伯維 (AbbVie) 的 EMBLAVEO（氨曲南和阿維巴坦）獲得 FDA 批准，用於治療複雜性腹腔內感染。此類核准可望開拓新的收入來源，並增強未來市場成長。

市場趨勢

影響抗生素市場的關鍵趨勢是全球抗菌藥物管理計劃 (ASP) 的普及。這些計劃旨在促進合理使用抗生素，減少抗藥性細菌，並改善治療效果。

2024 年 3 月，ASPIRE 計畫在非洲啟動，旨在透過數位化創新、教育和政策幹預來改善抗生素的使用。此類計劃正在重新定義全球抗生素處方實踐。

依細分市場分析

  • 依藥物類別：

預計到 2026 年，青黴素類藥物將佔市場主導地位，市場佔有率將達到 28.59%，這主要得益於其價格優勢和仿製藥的興起。由於監管部門的批准和廣譜抗菌活性，頭孢菌素類藥物預計將以更高的複合年增長率成長。

  • 依應用領域劃分：

受肺炎和其他呼吸系統疾病在全球範圍內的高發生影響，呼吸道感染領域預計到 2026 年將佔市場主導地位，市場佔有率達 23.75%。

  • 依給藥途徑劃分：

預計到 2026 年，腸外抗生素將佔 58.08% 的市場佔有率，這主要得益於其對嚴重感染和醫院獲得性感染的有效性。

  • 依分銷管道劃分：

預計到 2026 年，醫院藥局將佔領先地位，市佔率達 60.71%，而線上藥局預計將擁有最快的成長速度。

區域展望

  • 北美：預計2025年市場規模為194.9億美元，2026年為202.6億美元。
  • 亞太地區：由於低成本仿製藥的高消費量和供應充足，預計該地區將以最高的複合年增長率增長。
  • 歐洲：擁有強大的研發生態系統和對創新抗生素的監管支援。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵洞察

  • 主要公司產品線分析
  • 抗菌藥物治療指引概要
  • 世界衛生組織發布的重點病原體抗生素抗藥性概要
  • 主要產業發展動態－併購、合作等
  • 新冠疫情對全球抗生素市場的影響

第五章：全球抗生素市場分析、洞察與預測 (2021-2034)

  • 按藥物類別劃分的市場分析、洞察與預測
    • 青黴素類
    • 頭孢菌素類
    • 氨基糖苷類
    • 四環素類
    • 大環內酯類
    • 氟喹諾酮類
    • 磺胺類
    • 其他
  • 按應用劃分的市場分析、洞察與預測
    • 皮膚感染
    • 呼吸道感染
    • 泌尿道感染
    • 敗血症
    • 耳部感染
    • 胃腸道感染
    • 其他
  • 依給藥途徑劃分的市場分析、洞察與預測給藥途徑
    • 口服
    • 腸外給藥
    • 其他
  • 市場分析、洞察與預測 - 按銷售管道劃分
    • 醫院藥房
    • 零售藥房
    • 線上藥房
  • 市場分析、洞察與預測 - 按地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美抗生素市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲抗生素市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第八章 亞太地區抗生素市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章 拉丁美洲抗生素市場分析、洞察與預測（2021-2034）

  • 依國家/地區
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章：中東和非洲抗生素市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會 (GCC)
    • 南非
    • 中東和非洲其他地區

第十一章 競爭分析

  • 全球市佔率分析（2025）
  • 公司簡介
  • 葛蘭素史克 (GSK plc)
  • 百時美施貴寶 (Bristol-Myers Squibb Company)
  • 山德士集團 (Sandoz Group AG)
  • 默克公司 (Merck & Co., Inc.)
  • 輝瑞公司 (Pfizer Inc.)
  • 強生服務公司 (Johnson & Johnson Services, Inc.)
  • 拜耳 (Bayer)股份公司
  • 艾伯維公司
  • 鹽野木工業株式會社
  • 雅培
  • 安斯泰來藥廠
Product Code: FBI104583

Growth Factors of antibiotics Market

The global antibiotics market plays a vital role in modern healthcare by treating a wide range of bacterial infections affecting millions of patients worldwide. Antibiotics are commonly used for respiratory infections, urinary tract infections (UTIs), skin infections, gastrointestinal infections, septicemia, and other serious conditions. Despite growing concerns around antimicrobial resistance (AMR), antibiotics remain essential, driving sustained market demand.

Market Size and Forecast

According to Fortune Business Insights, the global antibiotics market size was valued at USD 43.17 billion in 2025. The market is projected to grow to USD 44.84 billion in 2026 and further reach USD 64.38 billion by 2034, expanding at a CAGR of 4.40% during the forecast period (2026-2034).

North America dominated the market in 2025 with a 45.44% market share, supported by advanced healthcare infrastructure, high prescription rates, and strong presence of leading pharmaceutical companies.

Market Drivers

One of the primary drivers of the antibiotics market is the rising prevalence of bacterial infections globally. Conditions such as tuberculosis, pneumonia, UTIs, surgical site infections, and bloodstream infections continue to increase demand for effective antibacterial therapies.

For instance, as per the WHO Global Tuberculosis Report 2024, approximately 10.8 million people worldwide were affected by tuberculosis in 2023. Additionally, healthcare-associated infections (HAIs) remain a major concern, with 1 in 10 patients globally affected, particularly in low- and middle-income countries. These factors significantly propel antibiotic consumption and market growth.

Another major driver is the increase in research and development (R&D) activities, especially focused on addressing drug-resistant infections through novel and combination antibiotic therapies.

Market Restraints

Despite strong demand, the market faces restraints due to stringent regulations aimed at reducing antibiotic misuse and overuse. Governments and healthcare authorities are actively implementing antimicrobial stewardship programs to combat AMR.

Data published in The Lancet highlights that antimicrobial resistance directly caused 1.14 million deaths in 2021, with projections estimating up to 10 million deaths annually by 2050 if current trends continue. Moreover, AMR is expected to add USD 1.0 trillion in healthcare costs by 2050, placing additional strain on healthcare systems and limiting antibiotic adoption.

Market Opportunities

The growing burden of antibiotic-resistant infections presents a significant opportunity for the development of novel and advanced antibiotic therapies. Pharmaceutical companies are increasingly focusing on combination drugs and next-generation antibiotics.

For example, in February 2025, AbbVie Inc. received FDA approval for EMBLAVEO (aztreonam and avibactam) for treating complicated intra-abdominal infections. Such approvals are expected to unlock new revenue streams and strengthen future market growth.

Market Trends

A key trend shaping the antibiotics market is the global adoption of Antimicrobial Stewardship Programs (ASPs). These initiatives aim to promote responsible antibiotic use, reduce resistance, and improve treatment outcomes.

In March 2024, the ASPIRE initiative launched in Africa to enhance antibiotic usage through digital innovation, education, and policy interventions. Such programs are redefining antibiotic prescribing practices worldwide.

Segmentation Insights

  • By Drug Class:

Penicillin dominated the market, accounting for 28.59% share in 2026, driven by affordability and increasing generic launches. Cephalosporins are expected to grow at a higher CAGR due to regulatory approvals and broad-spectrum efficacy.

  • By Application:

The respiratory infections segment led with a 23.75% share in 2026, supported by the high global burden of pneumonia and other respiratory diseases.

  • By Route of Administration:

Parenteral antibiotics held 58.08% market share in 2026, mainly due to their effectiveness in severe and hospital-acquired infections.

  • By Distribution Channel:

Hospital pharmacies dominated with 60.71% market share in 2026, while online pharmacies are projected to grow at the fastest rate.

Regional Outlook

  • North America: Market valued at USD 19.49 billion in 2025 and USD 20.26 billion in 2026.
  • Asia Pacific: Expected to grow at the highest CAGR due to high consumption and availability of low-cost generics.
  • Europe: Strong R&D ecosystem and regulatory support for innovative antibiotics.

Competitive Landscape

The market is semi-fragmented, with key players including Pfizer Inc., Sandoz Group AG, Astellas Pharma Inc., Merck & Co., GSK plc, and AbbVie Inc. These companies focus on generic expansion, R&D investment, acquisitions, and collaborations to strengthen global presence.

Conclusion

In conclusion, the global antibiotics market is set for steady growth from USD 43.17 billion in 2025 to USD 64.38 billion by 2034, despite regulatory challenges and antimicrobial resistance concerns. Rising bacterial infections, increased R&D investment, and the development of novel combination therapies continue to support market expansion. While antimicrobial stewardship programs may reduce misuse, they also promote sustainable and effective antibiotic utilization, ensuring long-term market stability and innovation-driven growth.

Segmentation Drug Class, Application, Route of Administration, Distribution Channel, and Region

By Drug Class * Penicillin

  • Cephalosporin
  • Aminoglycosides
  • Tetracycline
  • Macrolides
  • Fluoroquinolones
  • Sulfonamides
  • Others

By Application * Skin Infections

  • Respiratory Infections
  • Urinary Tract Infections
  • Septicemia
  • Ear Infection
  • Gastrointestinal Infections
  • Others

By Route of Administration * Oral

  • Parenteral
  • Others

By Distribution Channel * Hospital Pharmacy

  • Retail Pharmacy
  • Online Pharmacy

By Region * North America (By Drug Class, Application, Route of Administration, Distribution Channel, and Country)

    • U.S.
    • Canada
  • Europe (By Drug Class, Application, Route of Administration, Distribution Channel, and Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Drug Class, Application, Route of Administration, Distribution Channel, and Country/Sub-region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Drug Class, Application, Route of Administration, Distribution Channel, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Drug Class, Application, Route of Administration, Distribution Channel, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Market Scope
  • 1.2. Market Segmentation
  • 1.3. Market Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Pipeline Analysis, By Key Players
  • 4.2. Overview of Antimicrobial Treatment Guidelines
  • 4.3. Overview of the Antibiotic resistant "Priority Pathogens" Published by WHO
  • 4.4. Key Industry Developments- Mergers, Acquisitions, Partnerships, etc.
  • 4.5. Impact of COVID 19 on Global Antibiotics Market

5. Global Antibiotics Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Drug Class
    • 5.1.1. Penicillin
    • 5.1.2. Cephalosporin
    • 5.1.3. Aminoglycosides
    • 5.1.4. Tetracyclines
    • 5.1.5. Macrolides
    • 5.1.6. Fluoroquinolones
    • 5.1.7. Sulfonamides
    • 5.1.8. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Skin Infections
    • 5.2.2. Respiratory Infections
    • 5.2.3. Urinary Tract Infections
    • 5.2.4. Septicemia
    • 5.2.5. Ear Infection
    • 5.2.6. Gastrointestinal Infections
    • 5.2.7. Others
  • 5.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.3.1. Oral
    • 5.3.2. Parenteral
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.4.1. Hospital Pharmacy
    • 5.4.2. Retail Pharmacy
    • 5.4.3. Online Pharmacy
  • 5.5. Market Analysis, Insights and Forecast - By Geography
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Antibiotics Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Drug Class
    • 6.1.1. Penicillin
    • 6.1.2. Cephalosporin
    • 6.1.3. Aminoglycosides
    • 6.1.4. Tetracyclines
    • 6.1.5. Macrolides
    • 6.1.6. Fluoroquinolones
    • 6.1.7. Sulfonamides
    • 6.1.8. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Skin Infections
    • 6.2.2. Respiratory Infections
    • 6.2.3. Urinary Tract Infections
    • 6.2.4. Septicemia
    • 6.2.5. Ear Infection
    • 6.2.6. Gastrointestinal Infections
    • 6.2.7. Others
  • 6.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.3.1. Oral
    • 6.3.2. Parenteral
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.4.1. Hospital Pharmacy
    • 6.4.2. Retail Pharmacy
    • 6.4.3. Online Pharmacy
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Antibiotics Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Drug Class
    • 7.1.1. Penicillin
    • 7.1.2. Cephalosporin
    • 7.1.3. Aminoglycosides
    • 7.1.4. Tetracyclines
    • 7.1.5. Macrolides
    • 7.1.6. Fluoroquinolones
    • 7.1.7. Sulfonamides
    • 7.1.8. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Skin Infections
    • 7.2.2. Respiratory Infections
    • 7.2.3. Urinary Tract Infections
    • 7.2.4. Septicemia
    • 7.2.5. Ear Infection
    • 7.2.6. Gastrointestinal Infections
    • 7.2.7. Others
  • 7.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.3.1. Oral
    • 7.3.2. Parenteral
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.4.1. Hospital Pharmacy
    • 7.4.2. Retail Pharmacy
    • 7.4.3. Online Pharmacy
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Antibiotics Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Drug Class
    • 8.1.1. Penicillin
    • 8.1.2. Cephalosporin
    • 8.1.3. Aminoglycosides
    • 8.1.4. Tetracyclines
    • 8.1.5. Macrolides
    • 8.1.6. Fluoroquinolones
    • 8.1.7. Sulfonamides
    • 8.1.8. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Skin Infections
    • 8.2.2. Respiratory Infections
    • 8.2.3. Urinary Tract Infections
    • 8.2.4. Septicemia
    • 8.2.5. Ear Infection
    • 8.2.6. Gastrointestinal Infections
    • 8.2.7. Others
  • 8.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.3.1. Oral
    • 8.3.2. Parenteral
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.4.1. Hospital Pharmacy
    • 8.4.2. Retail Pharmacy
    • 8.4.3. Online Pharmacy
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Antibiotics Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Drug Class
    • 9.1.1. Penicillin
    • 9.1.2. Cephalosporin
    • 9.1.3. Aminoglycosides
    • 9.1.4. Tetracyclines
    • 9.1.5. Macrolides
    • 9.1.6. Fluoroquinolones
    • 9.1.7. Sulfonamides
    • 9.1.8. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Skin Infections
    • 9.2.2. Respiratory Infections
    • 9.2.3. Urinary Tract Infections
    • 9.2.4. Septicemia
    • 9.2.5. Ear Infection
    • 9.2.6. Gastrointestinal Infections
    • 9.2.7. Others
  • 9.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.3.1. Oral
    • 9.3.2. Parenteral
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.4.1. Hospital Pharmacy
    • 9.4.2. Retail Pharmacy
    • 9.4.3. Online Pharmacy
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Antibiotics Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Drug Class
    • 10.1.1. Penicillin
    • 10.1.2. Cephalosporin
    • 10.1.3. Aminoglycosides
    • 10.1.4. Tetracyclines
    • 10.1.5. Macrolides
    • 10.1.6. Fluoroquinolones
    • 10.1.7. Sulfonamides
    • 10.1.8. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Skin Infections
    • 10.2.2. Respiratory Infections
    • 10.2.3. Urinary Tract Infections
    • 10.2.4. Septicemia
    • 10.2.5. Ear Infection
    • 10.2.6. Gastrointestinal Infections
    • 10.2.7. Others
  • 10.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.3.1. Oral
    • 10.3.2. Parenteral
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.4.1. Hospital Pharmacy
    • 10.4.2. Retail Pharmacy
    • 10.4.3. Online Pharmacy
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
    • 11.2.1. GSK plc
    • 11.2.2. Bristol-Myers Squibb Company
    • 11.2.3. Sandoz Group AG
    • 11.2.4. Merck & Co., Inc.
    • 11.2.5. Pfizer Inc.
    • 11.2.6. Johnson & Johnson Services, Inc.
    • 11.2.7. Bayer AG
    • 11.2.8. AbbVie Inc
    • 11.2.9. Shionogi & Co., Ltd.
    • 11.2.10. Abbott
    • 11.2.11. Astellas Pharma Inc.

List of Tables

  • Table 1: Global Antibiotics Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034
  • Table 2: Global Antibiotics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 3: Global Antibiotics Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 4: Global Antibiotics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 5: Global Antibiotics Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Antibiotics Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034
  • Table 7: North America Antibiotics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 8: North America Antibiotics Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 9: North America Antibiotics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 10: North America Antibiotics Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Antibiotics Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034
  • Table 12: Europe Antibiotics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 13: Europe Antibiotics Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 14: Europe Antibiotics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 15: Europe Antibiotics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Antibiotics Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034
  • Table 17: Asia Pacific Antibiotics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 18: Asia Pacific Antibiotics Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 19: Asia Pacific Antibiotics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 20: Asia Pacific Antibiotics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America Antibiotics Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034
  • Table 22: Latin America Antibiotics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23: Latin America Antibiotics Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 24: Latin America Antibiotics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 25: Latin America Antibiotics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Antibiotics Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034
  • Table 27: Middle East & Africa Antibiotics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 28: Middle East & Africa Antibiotics Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 29: Middle East & Africa Antibiotics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 30: Middle East & Africa Antibiotics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Antibiotics Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Antibiotics Market Value Share (%), by Drug Class, 2025 & 2034
  • Figure 3: Global Antibiotics Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Antibiotics Market Value Share (%), by Route of Administration, 2025 & 2034
  • Figure 5: Global Antibiotics Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 6: Global Antibiotics Market Value Share (%), by Region, 2025 & 2034
  • Figure 7: North America Antibiotics Market Value (USD billion), by Drug Class, 2025 & 2034
  • Figure 8: North America Antibiotics Market Value Share (%), by Drug Class, 2025
  • Figure 9: North America Antibiotics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 10: North America Antibiotics Market Value Share (%), by Application, 2025
  • Figure 11: North America Antibiotics Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 12: North America Antibiotics Market Value Share (%), by Route of Administration, 2025
  • Figure 13: North America Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 14: North America Antibiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 15: North America Antibiotics Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Antibiotics Market Value Share (%), By Country, 2025
  • Figure 17: Europe Antibiotics Market Value (USD billion), by Drug Class, 2025 & 2034
  • Figure 18: Europe Antibiotics Market Value Share (%), by Drug Class, 2025
  • Figure 19: Europe Antibiotics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 20: Europe Antibiotics Market Value Share (%), by Application, 2025
  • Figure 21: Europe Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 22: Europe Antibiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 23: Europe Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 24: Europe Antibiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 25: Europe Antibiotics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Antibiotics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Antibiotics Market Value (USD billion), by Drug Class, 2025 & 2034
  • Figure 28: Asia Pacific Antibiotics Market Value Share (%), by Drug Class, 2025
  • Figure 29: Asia Pacific Antibiotics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 30: Asia Pacific Antibiotics Market Value Share (%), by Application, 2025
  • Figure 31: Asia Pacific Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 32: Asia Pacific Antibiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 33: Asia Pacific Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 34: Asia Pacific Antibiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 35: Asia Pacific Antibiotics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Antibiotics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Antibiotics Market Value (USD billion), by Drug Class, 2025 & 2034
  • Figure 38: Latin America Antibiotics Market Value Share (%), by Drug Class, 2025
  • Figure 39: Latin America Antibiotics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 40: Latin America Antibiotics Market Value Share (%), by Application, 2025
  • Figure 41: Latin America Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 42: Latin America Antibiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 43: Latin America Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 44: Latin America Antibiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 45: Latin America Antibiotics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Antibiotics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Antibiotics Market Value (USD billion), by Drug Class, 2025 & 2034
  • Figure 48: Middle East & Africa Antibiotics Market Value Share (%), by Drug Class, 2025
  • Figure 49: Middle East & Africa Antibiotics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 50: Middle East & Africa Antibiotics Market Value Share (%), by Application, 2025
  • Figure 51: Middle East & Africa Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 52: Middle East & Africa Antibiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 53: Middle East & Africa Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 54: Middle East & Africa Antibiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 55: Middle East & Africa Antibiotics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Antibiotics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Antibiotics Market Share (%), By Company, 2025